Comment
doi: 10.1056/NEJM200109273451312.
Trastuzumab and breast cancer
- PMID: 11575295
- DOI: 10.1056/NEJM200109273451312
Item in Clipboard
Comment
Trastuzumab and breast cancer
N Engl J Med.
.
No abstract available
Comment on
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.N Engl J Med. 2001 Mar 15;344(11):783-92. doi: 10.1056/NEJM200103153441101. N Engl J Med. 2001. PMID: 11248153 Clinical Trial.
-
From the molecule to the clinic--inhibiting HER2 to treat breast cancer.N Engl J Med. 2001 Mar 15;344(11):841-2. doi: 10.1056/NEJM200103153441110. N Engl J Med. 2001. PMID: 11248162 No abstract available.
Similar articles
-
Trastuzumab and breast cancer.N Engl J Med. 2001 Sep 27;345(13):996-7. N Engl J Med. 2001. PMID: 11575297 No abstract available.
-
From the molecule to the clinic--inhibiting HER2 to treat breast cancer.N Engl J Med. 2001 Mar 15;344(11):841-2. doi: 10.1056/NEJM200103153441110. N Engl J Med. 2001. PMID: 11248162 No abstract available.
-
Cardiotoxicity concerns prompt data review in breast cancer trial.J Natl Cancer Inst. 2002 May 1;94(9):650-1. doi: 10.1093/jnci/94.9.650. J Natl Cancer Inst. 2002. PMID: 11983752 No abstract available.
-
[Trastuzumab for treatment of advanced breast cancers].Nihon Rinsho. 2000 Apr;58 Suppl:340-4. Nihon Rinsho. 2000. PMID: 11026016 Review. Japanese. No abstract available.
-
Controversies in the use of adjuvant trastuzumab (Herceptin).J Br Menopause Soc. 2006 Dec;12(4):172-4. doi: 10.1258/136218006779160517. J Br Menopause Soc. 2006. PMID: 17178019 Review.
Cited by
-
Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine.Front Mol Biosci. 2023 Mar 2;10:1144817. doi: 10.3389/fmolb.2023.1144817. eCollection 2023. Front Mol Biosci. 2023. PMID: 36936995 Free PMC article. Review.
-
The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis.Breast Cancer Res Treat. 2023 Feb;198(1):113-122. doi: 10.1007/s10549-022-06753-7. Epub 2022 Dec 31. Breast Cancer Res Treat. 2023. PMID: 36586037 Free PMC article.
-
The production of the first functional antibody mimetic in higher plants: the chloroplast makes the DARPin G3 for HER2 imaging in oncology.Biol Res. 2022 Oct 23;55(1):32. doi: 10.1186/s40659-022-00400-7. Biol Res. 2022. PMID: 36274167 Free PMC article.
-
The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer.Acta Naturae. 2022 Apr-Jun;14(2):4-15. doi: 10.32607/actanaturae.11611. Acta Naturae. 2022. PMID: 35923562 Free PMC article.
-
Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary.Front Oncol. 2022 Mar 30;12:723140. doi: 10.3389/fonc.2022.723140. eCollection 2022. Front Oncol. 2022. PMID: 35433426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
